Jingfeng Pharmaceutical(SZ:000908) Sou Hu Cai Jing·2025-08-03 23:26Group 1 - The core point of the article highlights that ST Jingfeng's shareholders have a pledge ratio of 12.63% of the total share capital, ranking 749th in the market as of the last trading day on August 1 [1] - ST Jingfeng's shareholders have pledged a total of 111 million shares across 11 transactions, with a total market value of 668 million yuan [1] - The company specializes in the research, manufacturing, and sales of pharmaceutical products, with key products including various injection solutions and capsules, many of which are unique in the national market and included in the national medical insurance [1] Group 2 - The stock price of ST Jingfeng has increased by 199.00% over the past year [1] - The chairman of the company is Zhang Li [1]